Targeting tumor-associated macrophages and granulocytic myeloid-derived suppressor cells augments PD-1 blockade in cholangiocarcinoma is a research paper published in Journal of Clinical Investigation (2020). On theSindex it has a DataRank of 0. It has been cited 399 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: 1K08CA236874
U.S. Department of Defense
Grant: W81XWH-18-1-0297
Mayo Hepatobiliary Cancer SPORE
Grant: P50 CA210964
American Gastroenterological Association
Grant: Research Scholar Award
NIH/NIDDK
Grant: T32DK07198
Cholangiocarcinoma Foundation
Grant: Andrea Marie Fuquay Memorial Research Fellowship
Digestive Diseases Research Core Center, Mayo Clinic
Grant: Pilot
Digestive Diseases Research Core Center, Mayo Clinic
Grant: Feasibility Award P30DK084567
NIDDK NIH HHS
Grant: P30 DK084567
NIDDK NIH HHS
Grant: T32 DK007198
NCI NIH HHS
Grant: K08 CA236874
National Institutes of Health
Grant: 5K08CA236874-02
The Pro-Tumor Immunologic Niche of the Liver
National Institutes of Health
Grant: 3P50CA210964-02S1
Mayo Clinic Hepatobiliary SPORE Project 4 Diversity Supplement Dr. Barro Oumar
National Institutes of Health
Grant: 5P30DK084567-05
CLINICAL CORE
National Institutes of Health
Grant: 5T32DK007198-42
Multidisciplinary Training in Digestive Diseases
FWCI
16.04
Citation Percentile
1.0%
Influential Citations
9
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes
Additional file 1 of Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes
Additional file 2 of Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes
Additional file 2 of Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes
Additional file 3 of Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes
Additional file 3 of Common DNA methylation changes in biliary tract cancers identify subtypes with different immune characteristics and clinical outcomes
Additional file 1 of Single-cell RNA sequencing reveals enhanced antitumor immunity after combined application of PD-1 inhibitor and Shenmai injection in non-small cell lung cancer
Additional file 1 of Single-cell RNA sequencing reveals enhanced antitumor immunity after combined application of PD-1 inhibitor and Shenmai injection in non-small cell lung cancer
Additional file 2 of Single-cell RNA sequencing reveals enhanced antitumor immunity after combined application of PD-1 inhibitor and Shenmai injection in non-small cell lung cancer
Additional file 2 of Single-cell RNA sequencing reveals enhanced antitumor immunity after combined application of PD-1 inhibitor and Shenmai injection in non-small cell lung cancer
Additional file 1 of Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer
Additional file 1 of Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer
Additional file 1 of The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study
Additional file 1 of The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study
Additional file 2 of The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study
Additional file 2 of The combination of PD-L1 expression and the neutrophil-to-lymphocyte ratio as a prognostic factor of postoperative recurrence in non-small-cell lung cancer: a retrospective cohort study
Additional file 1 of Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model
Additional file 1 of Tumor immune dysfunction and exclusion subtypes in bladder cancer and pan-cancer: a novel molecular subtyping strategy and immunotherapeutic prediction model
Additional file 1 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer
Additional file 1 of Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer